Loading
PDBj
✖
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9ZNT

Cryo-EM structure of L9-yd19 in complex with Plasmodium falciparum circumsporozoite protein (PfCSP) 3D7 strain

Summary for 9ZNT
Entry DOI10.2210/pdb9znt/pdb
EMDB information74456
DescriptorCircumsporozoite protein, L9-yd19 heavy chain, L9-yd19 light chain (3 entities in total)
Functional Keywordsanti-malarial, pfcsp, immune system
Biological sourcePlasmodium falciparum 3D7
More
Total number of polymer chains7
Total formula weight118171.66
Authors
Tripathi, P.,Kwong, P.D. (deposition date: 2025-12-14, release date: 2026-10-21)
Primary citationChun, J.,Tripathi, P.,Flores-Garcia, Y.,Madan, B.,Lee, G.A.,Fahad, A.S.,Lei, H.,Teng, I.T.,Hurlburt, N.K.,Flynn, B.J.,Pancera, M.,Miura, K.,Zhou, T.,Idris, A.H.,Zavala, F.,Seder, R.A.,Kwong, P.D.,DeKosky, B.J.
Anti-malaria antibody engineering broadens recognition motifs and reveals new homotypic interactions that enhance protective breadth.
Nat Commun, 17:-, 2026
Cited by
PubMed Abstract: The monoclonal antibody L9 mediates high-level protection against malaria in children for up to 6 months in Africa. L9 preferentially binds with high affinity to a triplicate of NVDP-minor repeats on the P. falciparum circumsporozoite protein (PfCSP). Here, we sought to improve the affinity of L9 to enhance protection against rare strains with two spatially separated minor repeats or a single minor repeat. Site saturation mutagenesis and yeast display-screening identified a panel of affinity-improved variants. In vivo challenge showed one variant, L9_yd19, to be modestly more potent against a transgenic Plasmodium encoding chimeric CSP with two widely spaced minor repeats from a Kenyan parasite strain, with no loss in potency against the benchmark 3D7 strain with its standard complement of minor repeats. L9_yd19 also had high affinity against NANP-major repeats and was protective against transgenic Plasmodium expressing CSP with a NANP knock-in lacking NVDP. Cryo-EM studies revealed L9_yd19 to recognize PfCSP with two distinct homotypic interfaces, which combined to yield two trimeric layers of antibodies comprising asymmetric trimers that dimerized in a head-to-head fashion. These data reveal a new antibody mechanism that utilizes interfaces involving dual homotypic symmetry elements, a 2-fold and an asymmetric 3-fold, for improved malaria prevention.
PubMed: 42660882
DOI: 10.1038/s41467-026-75840-w
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.6 Å)
Structure validation

261584

PDB entries from 2026-10-28

PDB statisticsPDBj update infoContact PDBjnumon